Substrate specificity of human kallikreins 1 and 6 determined by phage display
暂无分享,去创建一个
Pengyu Y. Ren | G. Georgiou | M. Blaber | P. A. Golubkov | B. Hwang | Haixin Li | S. Blaber | B. Iverson | Gurunathan Laxmikanthan
[1] Jihun Lee,et al. Activation Profiles and Regulatory Cascades of the Human Kallikrein-related Peptidases* , 2007, Journal of Biological Chemistry.
[2] M. Blaber,et al. The autolytic regulation of human kallikrein-related peptidase 6. , 2007, Biochemistry.
[3] S. Diamond. Methods for mapping protease specificity. , 2007, Current opinion in chemical biology.
[4] G. Georgiou,et al. Substrate Specificity of the Escherichia coli Outer Membrane Protease OmpP , 2006, Journal of bacteriology.
[5] E. Diamandis,et al. Proteinase-activated Receptors, Targets for Kallikrein Signaling* , 2006, Journal of Biological Chemistry.
[6] C. Craik,et al. Specificity Profiling of Seven Human Tissue Kallikreins Reveals Individual Subsite Preferences* , 2006, Journal of Biological Chemistry.
[7] M. Blaber,et al. Substrate Specificity of Human Kallikrein 6 , 2006, Journal of Biological Chemistry.
[8] J. Whisstock,et al. Elucidation of the Substrate Specificity of the C1s Protease of the Classical Complement Pathway* , 2005, Journal of Biological Chemistry.
[9] M. Blaber,et al. 1.70 Å X‐ray structure of human apo kallikrein 1: Structural changes upon peptide inhibitor/substrate binding , 2005, Proteins.
[10] T. Kishi,et al. Enzymatic profiling of human kallikrein 14 using phage-display substrate technology , 2005, Biological chemistry.
[11] E. Chen,et al. Screening for protease substrate by polyvalent phage display. , 2005, Combinatorial chemistry & high throughput screening.
[12] K. Shoemaker,et al. Substrate Specificity of the Escherichia coli Outer Membrane Protease OmpT , 2004, Journal of bacteriology.
[13] E. Diamandis,et al. Human Kallikrein 6 Degrades Extracellular Matrix Proteins and May Enhance the Metastatic Potential of Tumour Cells , 2004, Tumor Biology.
[14] E. Diamandis,et al. Human tissue kallikreins: physiologic roles and applications in cancer. , 2004, Molecular cancer research : MCR.
[15] Tsutomu Hashikawa,et al. Alpha-synuclein degradation by serine protease neurosin: implication for pathogenesis of synucleinopathies. , 2003, Human molecular genetics.
[16] E. Diamandis,et al. Characterization of the enzymatic activity of human kallikrein 6: Autoactivation, substrate specificity, and regulation by inhibitors. , 2003, Biochemical and biophysical research communications.
[17] D. Katsaros,et al. Parallel overexpression of seven kallikrein genes in ovarian cancer. , 2003, Cancer research.
[18] D. Katsaros,et al. Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] D. Deperthes. Phage Display Substrate: A Blind Method for Determining Protease Specificity , 2002, Biological chemistry.
[20] Steven M. Thompson,et al. Crystal Structure and Biochemical Characterization of Human Kallikrein 6 Reveals That a Trypsin-like Kallikrein Is Expressed in the Central Nervous System* , 2002, The Journal of Biological Chemistry.
[21] J. Chagas,et al. Substrate specificity of human kallikrein 2 (hK2) as determined by phage display technology. , 2002, European journal of biochemistry.
[22] G. Yousef,et al. The new human tissue kallikrein gene family: structure, function, and association to disease. , 2001, Endocrine reviews.
[23] P. Nelson,et al. New nomenclature for the human tissue kallikrein gene family. , 2000, Clinical chemistry.
[24] J. Richardson,et al. The penultimate rotamer library , 2000, Proteins.
[25] S W Scherer,et al. Molecular characterization of zyme/protease M/neurosin (PRSS9), a hormonally regulated kallikrein-like serine protease. , 1999, Genomics.
[26] P. Worley,et al. Synphilin-1 associates with α-synuclein and promotes the formation of cytosolic inclusions , 1999, Nature Genetics.
[27] P. Isackson,et al. Nervous System-Specific Expression of a Novel Serine Protease: Regulation in the Adult Rat Spinal Cord by Excitotoxic Injury , 1997, The Journal of Neuroscience.
[28] James R. Miller,et al. Zyme, a Novel and Potentially Amyloidogenic Enzyme cDNA Isolated from Alzheimer’s Disease Brain* , 1997, The Journal of Biological Chemistry.
[29] L. Juliano,et al. Hydrolysis of somatostatin by human tissue kallikrein after the amino acid pair phe-Phe. , 1997, The Biochemical journal.
[30] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[31] T. Tanaka,et al. Molecular cloning of a novel trypsin-like serine protease (neurosin) preferentially expressed in brain. , 1997, Biochimica et biophysica acta.
[32] S. Mok,et al. A Novel Protease Homolog Differentially Expressed in Breast and Ovarian Cancer , 1996, Molecular medicine.
[33] L. Chao,et al. Kallistatin, a novel human tissue kallikrein inhibitor: levels in body fluids, blood cells, and tissues in health and disease. , 1996, The Journal of laboratory and clinical medicine.
[34] D. Evans,et al. Cleavage of human kininogen fragments at Met-Lys by human tissue kallikrein. , 1994, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[35] L. Chao,et al. Kallistatin: a novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence. , 1992, The Journal of biological chemistry.
[36] K. Bhoola,et al. Bioregulation of kinins: kallikreins, kininogens, and kininases. , 1992, Pharmacological reviews.
[37] J. Scott,et al. Searching for peptide ligands with an epitope library. , 1990, Science.
[38] S. Cohen,et al. Analysis of gene control signals by DNA fusion and cloning in Escherichia coli. , 1980, Journal of molecular biology.
[39] E. Diamandis,et al. The kallikrein world: an update on the human tissue kallikreins , 2006, Biological chemistry.
[40] G. Deléage,et al. Characterization of prostate‐specific antigen binding peptides selected by phage display technology , 2006, Journal of molecular recognition : JMR.
[41] F. Fiedler,et al. Substrate specificity of porcine pancreatic kallikrein. , 1979, Advances in experimental medicine and biology.